Search results for "immunity"

showing 10 items of 1537 documents

Innate Immune Cells' Contribution to Systemic Lupus Erythematosus

2019

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by the presence of autoantibodies against nuclear antigens, immune complex deposition, and tissue damage in the kidneys, skin, heart and lung. Because of the pathogenic role of antinuclear antibodies and autoreactive T cells in SLE, extensive efforts have been made to demonstrate how B cells act as antibody-producing or as antigen-presenting cells that can prime autoreactive T cell activation. With the discovery of new innate immune cells and inflammatory mediators, innate immunity is emerging as a key player in disease pathologies. Recent work over the last decade has highlighted the importance of innate immun…

lcsh:Immunologic diseases. AllergyAnti-nuclear antibodyMini ReviewT cellImmunologyPathogenesisAntigenimmune system diseasesmedicineAnimalsHumansLupus Erythematosus SystemicImmunology and Allergydendritic cellsskin and connective tissue diseasesinnate immunitylupus (SLE)Autoimmune diseaseInnate immune systembusiness.industryInnate lymphoid cellAutoantibodymedicine.diseaseImmunity Innatemacrophage-cellmedicine.anatomical_structureImmunologyinnate lymphoid celllcsh:RC581-607businessFrontiers in Immunology
researchProduct

Heat-Shock Proteins in Autoimmunity

2013

Heat shock proteins (HSPs), also known as “stress proteins,” are among the highly conserved and immunogenic proteins shared among diverse groups of microbial agents and mammals [1]. Heat and other types of stressful stimuli can increase the cellular expression of HSPs. These proteins have been categorized into different families according to their molecular mass, for example, HSP110, HSP90, HSP70, HSP60, HSP40, HSP20-30, and HSP10 [1–3]. For uniformity, guidelines for the nomenclature of various human HSP families have been proposed [4]. Under physiological conditions, the ubiquitously distributed HSPs maintain the integrity and function of other cellular proteins in stressful conditions. H…

lcsh:Immunologic diseases. AllergyArticle SubjectImmunologychemical and pharmacologic phenomenaBiologymedicine.disease_causeAutoimmunity03 medical and health sciences0302 clinical medicineImmune systemImmunology and Microbiology (miscellaneous)Heat shock proteinmedicineImmunology and Allergy030304 developmental biology0303 health sciencesInnate immune systemFOXP3Acquired immune system3. Good healthMolecular mimicryEditorialImmunologyHSP60lcsh:RC581-607030217 neurology & neurosurgeryAutoimmune Diseases
researchProduct

Are Toll-like receptors and decoy receptors involved in the immunopathogenesis of systemic lupus erythematosus and lupus-like syndromes?

2011

In this paper we focus our attention on the role of two families of receptors, Toll-like receptors (TLR) and decoy receptors (DcR) involved in the generation of systemic lupus erythematosus (SLE) and lupus-like syndromes in human and mouse models. To date, these molecules were described in several autoimmune disorders such as rheumatoid arthritis, antiphospholipids syndrome, bowel inflammation, and SLE. Here, we summarize the findings of recent investigations on TLR and DcR and their role in the immunopathogenesis of the SLE.

lcsh:Immunologic diseases. AllergyChemokineImmunologyInflammationAutoimmunityReview ArticleCell Communicationmedicine.disease_causeAutoantigensAutoimmunityMiceimmune system diseasesToll-like receptormedicineImmunology and AllergyAnimalsHumansLupus Erythematosus SystemicDecoy receptorsReceptorskin and connective tissue diseasesSettore MED/04 - Patologia GeneraleToll-like receptors decoy receptors systemicic erythematous lupusSystemic lupus erythematosusbiologybusiness.industryToll-Like ReceptorsGeneral Medicinemedicine.diseaseImmunity Innatedecoy receptorDisease Models AnimalTumor Necrosis Factor Decoy ReceptorsRheumatoid arthritisImmunologybiology.proteinsystemicic erythematous lupusmedicine.symptomChemokinesbusinesslcsh:RC581-607Tumor Necrosis Factor Decoy ReceptorsSignal Transduction
researchProduct

Immunological Monitoring to Rationally Guide AAV Gene Therapy

2013

Recent successes with adeno-associated virus (AAV)-based gene therapies fuel the hope for new treatments for hereditary diseases. Pre-existing as well as therapy-induced immune responses against both AAV and the encoded transgenes have been described and may impact on safety and efficacy of gene-therapy approaches. Consequently, monitoring of vector- and transgene-specific immunity is mandated and may rationally guide clinical development. Next to the humoral immune response, the cellular response is central in our understanding of the host reaction in gene therapy. But in contrast to the monitoring of antibodies, which has matured over many decades, sensitive and robust monitoring of T cel…

lcsh:Immunologic diseases. AllergyGenetic enhancementTransgeneImmunologyadeno-associated virus (AAV)Review Articleadeno-associated virusBioinformaticsmedicine.disease_causeImmune systemImmunityNeed to knowimmunological monitoringmedicineImmunology and Allergyassay harmonizationVector (molecular biology)Adeno-associated virusbiologybusiness.industrybiomarkersgene therapybiology.proteinAntibodylcsh:RC581-607businessFrontiers in Immunology
researchProduct

Report from the second cytomegalovirus and immunosenescence workshop

2011

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.; International audience; The Second International Workshop on CMV & Immunosenescence was held in Cambridge, UK, 2-4th December, 2010. The presentations covered four separate sessions: cytomegalovirus and T cell phenotypes; T cell memory frequency, inflation and immunosenescence; cytomegalovirus in aging, mortality and disease states; and the immunobiology of cytomegalovirus-specific T cells and effects of the virus on vacc…

lcsh:Immunologic diseases. AllergyGerontologyAging[SDV.IMM] Life Sciences [q-bio]/Immunology[SDV]Life Sciences [q-bio]ImmunologyCongenital cytomegalovirus infectionDiseaseAgeing CMV immunitylcsh:Geriatrics0601 Biochemistry and Cell BiologyVaccine Related03 medical and health sciences0302 clinical medicineSDG 3 - Good Health and Well-beingMedicinecytomegalovirusComputingMilieux_MISCELLANEOUS030304 developmental biologyimmunosenescence0303 health sciencesbusiness.industryGeriatrics gerontologyImmunosenescencemedicine.disease3. Good healthlcsh:RC952-954.6AgeingHCMV InfectionInfectious DiseasesCommentary/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being[SDV.IMM]Life Sciences [q-bio]/ImmunologyImmunizationlcsh:RC581-607business030215 immunology
researchProduct

HLA-Class II Artificial Antigen Presenting Cells in CD4+ T Cell-Based Immunotherapy

2019

CD4+ T cells differentiate into various T helper subsets characterized by distinct cytokine secreting profiles that confer them effector functions adapted to a variety of infectious or endogenous threats. Regulatory CD4+ T cells are another specialized subset that plays a fundamental role in the maintenance of immune tolerance to self-antigens. Manipulating effector or regulatory CD4+ T cells responses is a promising immunotherapy strategy for, respectively, chronical viral infections and cancer, or severe autoimmune diseases and transplantation. Adoptive cell therapy (ACT) is an emerging approach that necessitates defining robust and efficient methods for the in vitro expansion of antigen-…

lcsh:Immunologic diseases. AllergyHLA class II moleculesautoimmunityartificial antigen presenting cellscanceradoptive cell therapyCD4+ T lymphocyteslcsh:RC581-607Frontiers in Immunology
researchProduct

How the knowledge of interactions between meningococcus and the human immune system has been used to prepare effective Neisseria meningitidis vaccines

2015

In the last decades, tremendous advancement in dissecting the mechanisms of pathogenicity ofNeisseria meningitidisat a molecular level has been achieved, exploiting converging approaches of different disciplines, ranging from pathology to microbiology, immunology, and omics sciences (such as genomics and proteomics). Here, we review the molecular biology of the infectious agent and, in particular, its interactions with the immune system, focusing on both the innate and the adaptive responses. Meningococci exploit different mechanisms and complex machineries in order to subvert the immune system and to avoid being killed. Capsular polysaccharide and lipooligosaccharide glycan composition, in…

lcsh:Immunologic diseases. AllergyImmunologyGenomicsMeningococcal VaccinesMeningococcal vaccineReview ArticleBiologyMeningitis MeningococcalNeisseria meningitidisProteomicsmedicine.disease_causeImmune systemAntigenConjugate vaccineImmunityAnimals; Gram-Negative Bacteria; Host-Pathogen Interactions; Humans; Immunity; Meningitis Meningococcal; Meningococcal Vaccines; Neisseria meningitidis; Immune System; Immunology and Allergy; ImmunologyGram-Negative BacteriamedicineAnimalsHumansImmunology; Immunology and AllergyImmunology and AllergyNeisseria meningitidisImmunityGeneral MedicineVirologyImmune SystemHost-Pathogen Interactionslcsh:RC581-607
researchProduct

Antigen-specific T cells and cytokines detection as useful tool for understanding immunity against zoonotic infections.

2012

Zoonoses include a broad range of diseases, that are becoming of great interest, due to the climate changing, that cause the adaptation of vectors to new niches and environments. Host immune responses play a crucial role in determining the outcome of infections, as documented by expansion of antigen-specific T cells during several zoonotic infections. Thus, understanding of the contribution of antigen-specific T-cell subsets in the host immune response is a powerful tool to evaluate the different immunological mechanisms involved in zoonotic infections and for the development of effective vaccines. In this paper we discuss the role of T cells in some eukaryotic and prokaryotic infectious mo…

lcsh:Immunologic diseases. AllergyNematodaT-LymphocytesImmunologyReview ArticleAdaptive ImmunityBiologyHost-Parasite InteractionsImmune systemT-Lymphocyte SubsetsAntigen specificImmunityZoonosesAnimalsHumansImmunology and AllergyAntigensTh1-Th2 BalanceZoonoses antigen specific T-cells animal immunology.VaccinesBacteriaZoonotic InfectionGeneral MedicineAcquired immune systemVirologyImmunity InnateHost-Pathogen InteractionsImmunologyCytokinesAdaptationlcsh:RC581-607
researchProduct

Neuro-endocrine networks controlling immune system in health and disease

2014

The nervous and immune systems have long been considered as compartments that perform separate and different functions. However, recent clinical, epidemiological, and experimental data have suggested that the pathogenesis of several immune-mediated disorders, such as multiple sclerosis (MS), might involve factors, hormones, and neural mediators that link the immune and nervous system. These molecules are members of the same superfamily, which allow the mutual and bi-directional neural–immune interaction. More recently, the discovery of leptin, one of the most abundant adipocyte-derived hormones that control food intake and metabolism, has suggested that nutritional/metabolic status, acting …

lcsh:Immunologic diseases. AllergyNervous systemLeptinMultiple sclerosisExperimental autoimmune encephalomyelitisCentral nervous systemImmunologyAutoimmunityReview ArticleDiseaseMSBiologymedicine.diseaseBioinformatics3. Good healthImmune tolerancemedicine.anatomical_structureImmune systemMetabolismImmunopathologymedicineNeuro-immune modulationImmunology and Allergylcsh:RC581-607MS; autoimmunity; leptin; metabolism; neuro-immune modulation
researchProduct

Mechanisms of immunosenescence

2009

Abstract On April 7,8, 2009 a Symposium entitled "Pathophysiology of Successful and Unsuccessful Ageing" took place in Palermo, Italy. Here, the lectures of G. Pawelec, D. Dunn-Walters and. G. Colonna-Romano on T and B immunosenescence are summarized. In the elderly, many alterations of both innate and acquired immunity have been described. Alterations to the immune system in the older person are generally viewed as a deterioration of immunity, leading to the use of the catch-all term immunosenescence. Indeed, many immunological parameters are often markedly different in elderly compared to young people, and some, mostly circumstantial, evidence suggests that retained function of both innat…

lcsh:Immunologic diseases. AllergyOlder personAgingbusiness.industryGeriatrics gerontologyImmunologyShort ReportImmunosenescencelcsh:GeriatricsAcquired immune systemImmune Dysfunctionhumanitieslcsh:RC952-954.6AgeingImmune systemCMV IMMUNOSENESCENCEAGEINGImmunityImmunologyMedicinelcsh:RC581-607businessImmunity & Ageing
researchProduct